A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

NCT01396408 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

137

Enrollment

NETWORK

Sponsor class

Conditions

Advanced Rare Tumours

Interventions

DRUG: Sunitinib
DRUG: Temsirolimus

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]